CHANGES OF HEMODYNAMICS DURING THE DEVELOPMENT OF RESPIRATORY FAILURE IN PATIENTS WITH SEVERE FORMS OF COVID-19
Abstract
Background. The search for effective predictors of the severity of COVID-19 is an important problem in medical science at the present stage. In the pathogenesis of the severe course of a new coronavirus infection, changes in the state of hemodynamics are essential. Aim: to identify hemodynamic predictors of decompensated respiratory failure in patients with COVID-19. Materials and methods. The study was carried out on 100 patients of both sexes with community-acquired polysegmental viral-bacterial pneumonia against the background of COVID-19. Next, the patients were divided into 2 groups based on the development of severe respiratory failure. The 1st group included 50 patients who did not require mechanical ventilation, the second included patients who were either undergoing mechanical ventilation at the time of the study or will be undergoing it in the future. The studies were carried out using a complex of hardware-software non-invasive study of central hemodynamics using volumetric compression oscillometry. Results. In patients with progression of respiratory failure against the background of the new coronavirus infection COVID-19, the value of stroke volume and index is 1.27 and 1.16 times less before the prone position, as well as 1.3 and 1.23 times after the prone position according to compared with patients in the favorable group. In addition, in group 2, the volumetric ejection velocity in the supine position was 1.26 times less, and in the stomach position it was 1.22 times less. The compliance of the vascular wall and the reaction of precapillaries in patients who required mechanical ventilation were lower by 1.19 and 1.81 times before proning, and by 1.28 and 2.04 times after proning. Conclusions. In patients with progression of severe respiratory failure against the background of the new coronavirus infection COVID-19, changes in stroke volume and index, volumetric ejection velocity, and vascular wall compliance were identified.
References
Авдеева И.В. и др. Влияние инфекции SARS-CoV-2 на структурно-функциональные свойства артерий. Известия высших учебных заведений. Поволжский регион. Медицинские науки. 2022; 2(62): 14–25.
Биличенко Т.Н. Факторы риска, иммунологические механизмы и биологические маркеры тяжелого течения COVID-19 (обзор исследований). Русский медицинский журнал. Медицинское обозрение. 2021; 5(5): 237–44.
Мудров В.А. Алгоритмы статистического анализа данных биомедицинских исследований с помощью пакета программ SPSS (доступным языком). Учебное пособие. М.: Логосфера. 2022; 143.
Шилин Д.С. и др. Влияние легочной гипертензии на функциональные и морфологические показатели сердечной деятельности при COVID-19. Туберкулез и болезни легких. 2022; 100(1): 19–25.
Шилин Д.С., Шаповалов К Г. Гемодинамика при переводе в прон-позицию пациентов с COVID-19. Общая реаниматология. 2021; 17(3): 32–41.
Altinay M. et al. Effect of early awake prone positioning application on prognosis in patients with acute respiratory failure due to COVID-19 pneumonia: a retrospective observational study. Brazilian Journal of Anesthesiology. 2022; 72: 194–9.
Georgiyants M. et al. Current conception about the pathogenesis and intensive care of severe COVID-19. ScienceRise: Medical Science. 2021; 5(44): 4–9.
Hou H. et al. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19. Clinical & Experimental Immunology. 2020; 201(1): 76–84.
Mason R.J. Pathogenesis of COVID-19 from a cell biology perspective. European Respiratory Journal. 2020; 55(4).
McBane R.D. Thromboembolism and the Pandemic. Journal of the American College of Cardiology. 2020; 76(18): 2073–5.
Naicker S. et al. The novel coronavirus 2019 epidemic and kidneys. Kidney international. 2020; 97(5): 824–8.
Pagliano P. et al. Characteristics of viral pneumonia in the COVID-19 era: an update. Infection. 2021; 49: 607–16.
Petramala L. et al. Pulmonary embolism post-Covid-19 infection: physiopathological mechanisms and vascular damage biomarkers. Clinical and Experimental Medicine. 2023; 23(8): 4871–80.
Sanche S. et al. High contagiousness and rapid spread of severe acute respiratory syndrome coronavirus 2. Emerging infectious diseases. 2020; 26(7): 1470.
Sadeghi Dousari A., Taati Moghadam M., Satarzadeh N. COVID-19 (Coronavirus disease 2019): a new coronavirus disease. Infection and drug resistance. 2020: 2819–28.
Tajbakhsh A. et al. COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Review of Anti-infective Therapy. 2021; 19(3): 345–57.
Wiersinga W.J. et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020; 324(8): 782–93.
Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13): 1239–42.
Copyright (c) 2024 Russian Biomedical Research

This work is licensed under a Creative Commons Attribution 4.0 International License.